FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methyldopa Tablets
Status: Currently in Shortage
»Date first posted: 08/30/2018
»Therapeutic Categories: Cardiovascular

Expand all

Accord Healthcare Inc. (New 08/30/2018)

Company Contact Information:
866-941-7875

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Methyldopa 250 mg 100s (16729-03-001) Limited availability; Estimated shortage until Q1 CY 2019 API procurement delay
Methyldopa 250 mg 500s (16729-03-016) Limited availability; Estimated shortage until Q1 CY 2019 API procurement delay
Methyldopa 500 mg 100s (16729-03-101) Limited availability; Estimated shortage until Q1 CY 2019 API procurement delay
Methyldopa 500 mg 500s (16729-03-116) Limited availability; Estimated shortage until Q1 CY 2019 API procurement delay

Mylan Pharmaceuticals Inc. (Reverified 09/12/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg (NDC 0378-0611-01) Currently out of stock. Estimated re-supply: April 2019 Other
500 mg (NDC 0378-0421-01) Currently out of stock. Estimated re-supply: April 2019 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English